$0.51
+0.00 (+0.39%)
Open$0.52
Previous Close$0.51
Day High$0.53
Day Low$0.51
52W High$34.66
52W Low$12.32
Volume—
Avg Volume395.8K
Market Cap10.94M
P/E Ratio25.88
EPS$0.95
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+5,297.7% upside
Current
$0.51
$0.51
Target
$27.69
$27.69
$21.92
$27.69 avg
$40.08
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.62M | 3.54M | 3.93M |
| Net Income | -89,087 | -86,327 | -108,943 |
| Profit Margin | -2.5% | -2.4% | -2.8% |
| EBITDA | -137,252 | -134,724 | -147,370 |
| Free Cash Flow | -56,767 | -61,141 | -91,187 |
| Rev Growth | +10.0% | +8.8% | +5.3% |
| Debt/Equity | 0.67 | 0.64 | 0.81 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |